Vaccinex, Inc. (VCNX): Total Assets
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$2.60M
As of 2024-12-31
-35.9%
3-year compound annual growth
-10.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $2.60M | -28.5% | 2025-04-15, Balance as of period end |
| 2023-12-31 | $3.63M | -54.5% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $7.98M | -19.0% | 2024-04-25, Balance as of period end |
| 2021-12-31 | $9.84M | -15.9% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $11.70M | +154.2% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $4.60M | -79.1% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $22.03M | +295.1% | 2020-03-09, Balance as of period end |
| 2017-12-31 | $5.58M | n/a | 2019-03-13, Balance as of period end |